Cargando…

Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy

BACKGROUND: Diabetic cardiomyopathy (DCM) results from pathological changes in cardiac structure and function caused by diabetes. Excessive oxidative stress is an important feature of DCM pathogenesis. MicroRNAs (miRNAs) are key regulators of oxidative stress in the cardiovascular system. In the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Manli, Sun, Yangyong, Shan, Xinghua, Yang, Fan, Chu, Guojun, Chen, Qian, Han, Lin, Guo, Zhifu, Wang, Guokun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548149/
https://www.ncbi.nlm.nih.gov/pubmed/36209049
http://dx.doi.org/10.1186/s11658-022-00379-9
_version_ 1784805382628048896
author Yu, Manli
Sun, Yangyong
Shan, Xinghua
Yang, Fan
Chu, Guojun
Chen, Qian
Han, Lin
Guo, Zhifu
Wang, Guokun
author_facet Yu, Manli
Sun, Yangyong
Shan, Xinghua
Yang, Fan
Chu, Guojun
Chen, Qian
Han, Lin
Guo, Zhifu
Wang, Guokun
author_sort Yu, Manli
collection PubMed
description BACKGROUND: Diabetic cardiomyopathy (DCM) results from pathological changes in cardiac structure and function caused by diabetes. Excessive oxidative stress is an important feature of DCM pathogenesis. MicroRNAs (miRNAs) are key regulators of oxidative stress in the cardiovascular system. In the present study, we screened for the expression of oxidative stress-responsive miRNAs in the development of DCM. Furthermore, we aimed to explore the mechanism and therapeutic potential of miR-92a-2-5p in preventing diabetes-induced myocardial damage. METHODS: An experimental type 2 diabetic (T2DM) rat model was induced using a high-fat diet and low-dose streptozotocin (30 mg/kg). Oxidative stress injury in cardiomyocytes was induced by high glucose (33 mmol/L). Oxidative stress-responsive miRNAs were screened by quantitative real-time PCR. Intervention with miR-92a-2-5p was accomplished by tail vein injection of agomiR in vivo or adenovirus transfection in vitro. RESULTS: The expression of miR-92a-2-5p in the heart tissues was significantly decreased in the T2DM group. Decreased miR-92a-2-5p expression was also detected in high glucose-stimulated cardiomyocytes. Overexpression of miR-92a-2-5p attenuated cardiomyocyte oxidative stress injury, as demonstrated by increased glutathione level, and reduced reactive oxygen species accumulation, malondialdehyde and apoptosis levels. MAPK interacting serine/threonine kinase 2 (MKNK2) was verified as a novel target of miR-92a-2-5p. Overexpression of miR-92a-2-5p in cardiomyocytes significantly inhibited MKNK2 expression, leading to decreased phosphorylation of p38-MAPK signaling, which, in turn, ameliorated cardiomyocyte oxidative stress injury. Additionally, diabetes-induced myocardial damage was significantly alleviated by the injection of miR-92a-2-5p agomiR, which manifested as a significant improvement in myocardial remodeling and function. CONCLUSIONS: miR-92a-2-5p plays an important role in cardiac oxidative stress, and may serve as a therapeutic target in DCM. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11658-022-00379-9.
format Online
Article
Text
id pubmed-9548149
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95481492022-10-10 Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy Yu, Manli Sun, Yangyong Shan, Xinghua Yang, Fan Chu, Guojun Chen, Qian Han, Lin Guo, Zhifu Wang, Guokun Cell Mol Biol Lett Research BACKGROUND: Diabetic cardiomyopathy (DCM) results from pathological changes in cardiac structure and function caused by diabetes. Excessive oxidative stress is an important feature of DCM pathogenesis. MicroRNAs (miRNAs) are key regulators of oxidative stress in the cardiovascular system. In the present study, we screened for the expression of oxidative stress-responsive miRNAs in the development of DCM. Furthermore, we aimed to explore the mechanism and therapeutic potential of miR-92a-2-5p in preventing diabetes-induced myocardial damage. METHODS: An experimental type 2 diabetic (T2DM) rat model was induced using a high-fat diet and low-dose streptozotocin (30 mg/kg). Oxidative stress injury in cardiomyocytes was induced by high glucose (33 mmol/L). Oxidative stress-responsive miRNAs were screened by quantitative real-time PCR. Intervention with miR-92a-2-5p was accomplished by tail vein injection of agomiR in vivo or adenovirus transfection in vitro. RESULTS: The expression of miR-92a-2-5p in the heart tissues was significantly decreased in the T2DM group. Decreased miR-92a-2-5p expression was also detected in high glucose-stimulated cardiomyocytes. Overexpression of miR-92a-2-5p attenuated cardiomyocyte oxidative stress injury, as demonstrated by increased glutathione level, and reduced reactive oxygen species accumulation, malondialdehyde and apoptosis levels. MAPK interacting serine/threonine kinase 2 (MKNK2) was verified as a novel target of miR-92a-2-5p. Overexpression of miR-92a-2-5p in cardiomyocytes significantly inhibited MKNK2 expression, leading to decreased phosphorylation of p38-MAPK signaling, which, in turn, ameliorated cardiomyocyte oxidative stress injury. Additionally, diabetes-induced myocardial damage was significantly alleviated by the injection of miR-92a-2-5p agomiR, which manifested as a significant improvement in myocardial remodeling and function. CONCLUSIONS: miR-92a-2-5p plays an important role in cardiac oxidative stress, and may serve as a therapeutic target in DCM. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11658-022-00379-9. BioMed Central 2022-10-08 /pmc/articles/PMC9548149/ /pubmed/36209049 http://dx.doi.org/10.1186/s11658-022-00379-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Yu, Manli
Sun, Yangyong
Shan, Xinghua
Yang, Fan
Chu, Guojun
Chen, Qian
Han, Lin
Guo, Zhifu
Wang, Guokun
Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy
title Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy
title_full Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy
title_fullStr Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy
title_full_unstemmed Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy
title_short Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy
title_sort therapeutic overexpression of mir-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548149/
https://www.ncbi.nlm.nih.gov/pubmed/36209049
http://dx.doi.org/10.1186/s11658-022-00379-9
work_keys_str_mv AT yumanli therapeuticoverexpressionofmir92a25pamelioratedcardiomyocyteoxidativestressinjuryinthedevelopmentofdiabeticcardiomyopathy
AT sunyangyong therapeuticoverexpressionofmir92a25pamelioratedcardiomyocyteoxidativestressinjuryinthedevelopmentofdiabeticcardiomyopathy
AT shanxinghua therapeuticoverexpressionofmir92a25pamelioratedcardiomyocyteoxidativestressinjuryinthedevelopmentofdiabeticcardiomyopathy
AT yangfan therapeuticoverexpressionofmir92a25pamelioratedcardiomyocyteoxidativestressinjuryinthedevelopmentofdiabeticcardiomyopathy
AT chuguojun therapeuticoverexpressionofmir92a25pamelioratedcardiomyocyteoxidativestressinjuryinthedevelopmentofdiabeticcardiomyopathy
AT chenqian therapeuticoverexpressionofmir92a25pamelioratedcardiomyocyteoxidativestressinjuryinthedevelopmentofdiabeticcardiomyopathy
AT hanlin therapeuticoverexpressionofmir92a25pamelioratedcardiomyocyteoxidativestressinjuryinthedevelopmentofdiabeticcardiomyopathy
AT guozhifu therapeuticoverexpressionofmir92a25pamelioratedcardiomyocyteoxidativestressinjuryinthedevelopmentofdiabeticcardiomyopathy
AT wangguokun therapeuticoverexpressionofmir92a25pamelioratedcardiomyocyteoxidativestressinjuryinthedevelopmentofdiabeticcardiomyopathy